FORSITE DIAGNOSTICS
Desconocido
MALACTRES: Multi drug resistance in malaria under combination therapy Assessment of specific markers and devel...
FORSITE DIAGNOSTICS LTD
participó en un
FP7:
This project aims to assess specific P. falciparum genetic markers for resistance to artemisinin-based combinations (ACT), and to develop in...
Financiado
Financiado
MYCORRAY: A MICROARRAY TOOL FOR EFFECTIVE CONTROL OF FUNGAL GRAPEVINE TRUNK DISEASES IN EUROPEAN VINEYARDS
FORSITE DIAGNOSTICS LTD
participó en un
FP7:
MYCORRAY addresses a need identified by winegrowing sector SMEs for early, reliable, simultaneous identification of the 11 most relevant gra...
Financiado
Financiado
DIAGMAL: Translation of the direct on blood PCR NALFIA system into an innovative near point of care diagnosti...
FORSITE DIAGNOSTICS LTD
participó en un
FP7:
Accurate diagnosis of malaria is essential to timely install proper treatment. Current diagnostic methods for malaria have limitations, such...
Financiado
Financiado
VITISENS: COST EFFECTIVE HAND HELD DEVICE FOR RAPID IN FIELD DETECTION OF FLAVENSCENCE DOREE PHYTOPLASMA IN GR...
FORSITE DIAGNOSTICS LTD
participó en un
FP7:
VITISENS proposes the development of an innovative hand-held device that integrates the three steps for accurate detection of nucleic acids...
Financiado
Financiado
UNIQUE-CHECK: Development of a unique means of detecting and proving illegal administration of recombinant somatot...
FORSITE DIAGNOSTICS LTD
participó en un
FP7:
The ability to increase milk production in cow by bovine somatotropin (BST) was first demonstrated in 1930’s. The use of recombinant bovine...
Financiado
Financiado
* No se disponen de datos de la empresa actual.